Kevin Phan1,2,3, Vincent Vinh Gia An1,2, Hakeem Ha3, Steven Phan1, Vincent Lam1,2, Henry Pleass1,2. 1. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. 2. Department of Surgery, Westmead Hospital, Sydney, New South Wales, Australia. 3. St Vincent's Clinical School, The University of New South Wales, Sydney, New South Wales, Australia.
Abstract
BACKGROUND: The number of elderly patients undergoing hepatic resection for surgical treatment of benign and malignant cancers is increasing. However, there is limited clinical data on the complications and long-term survival rates associated with liver surgery in the elderly patients (≥70 years) versus younger patients for malignant liver conditions. METHODS: Six electronic databases were searched for original published studies comparing elderly (≥70) versus younger (<70) cohorts for malignant liver tumours. Data were extracted and analysed according to predefined clinical endpoints. RESULTS: Twenty-seven comparative studies were identified, including 4769 elderly patients versus 15,855 younger patients (n = 20,624). There was significantly higher 30-day mortality in the elderly colorectal liver metastasis group (P < 0.00002) and significant difference between elderly and young in terms of overall survival (hazard ration (HR), 1.10; P = 0.02). However, there was no difference in disease-free survival (HR, 1.05; P = 0.27). Post-operative pneumonia, renal failure and infection were more frequent in the elderly group. CONCLUSIONS: Liver resection for malignant hepatic tumours in the elderly is associated with a greater 30-day mortality and overall mortality when compared with younger cohorts, but similar disease-free survival. Length of stay and transfusions were not significantly different while pneumonia, renal failure and infections were more frequent in the elderly group.
BACKGROUND: The number of elderly patients undergoing hepatic resection for surgical treatment of benign and malignant cancers is increasing. However, there is limited clinical data on the complications and long-term survival rates associated with liver surgery in the elderly patients (≥70 years) versus younger patients for malignant liver conditions. METHODS: Six electronic databases were searched for original published studies comparing elderly (≥70) versus younger (<70) cohorts for malignant liver tumours. Data were extracted and analysed according to predefined clinical endpoints. RESULTS: Twenty-seven comparative studies were identified, including 4769 elderly patients versus 15,855 younger patients (n = 20,624). There was significantly higher 30-day mortality in the elderly colorectal liver metastasis group (P < 0.00002) and significant difference between elderly and young in terms of overall survival (hazard ration (HR), 1.10; P = 0.02). However, there was no difference in disease-free survival (HR, 1.05; P = 0.27). Post-operative pneumonia, renal failure and infection were more frequent in the elderly group. CONCLUSIONS: Liver resection for malignant hepatic tumours in the elderly is associated with a greater 30-day mortality and overall mortality when compared with younger cohorts, but similar disease-free survival. Length of stay and transfusions were not significantly different while pneumonia, renal failure and infections were more frequent in the elderly group.
Authors: Markus Albertsmeier; Andrea Engel; Markus O Guba; Sebastian Stintzing; Tobias S Schiergens; Gabriele Schubert-Fritschle; Dieter Hölzel; Jens Werner; Martin K Angele; Jutta Engel Journal: Langenbecks Arch Surg Date: 2017-08-12 Impact factor: 3.445
Authors: Julie Hallet; Jesse Zuckerman; Matthew P Guttman; Tyler R Chesney; Barbara Haas; Alyson Mahar; Antoine Eskander; Wing C Chan; Amy Hsu; Victoria Barabash; Natalie Coburn Journal: Ann Surg Oncol Date: 2022-09-06 Impact factor: 4.339
Authors: Vinzent N Spetzler; Marlene Schepers; Hans O Pinnschmidt; Lutz Fischer; Björn Nashan; Jun Li Journal: Hepatobiliary Surg Nutr Date: 2019-04 Impact factor: 7.293